Similar articles

• Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles.

  van Wely M, Westergaard LG, Bossuyt PM, van der Veen F. van Wely M, et al. Fertil Steril. 2003 Nov;80(5):1121-2. doi: 10.1016/s0015-0282(03)02190-3. Fertil Steril. 2003. PMID: 14607560 No abstract available.
• Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction.

  Ola B, Afnan M, Hammadieh N. Ola B, et al. Hum Reprod. 2000 May;15(5):1208-9. doi: 10.1093/humrep/15.5.1208-a. Hum Reprod. 2000. PMID: 10783383 No abstract available.
• Recombinant or urinary gonadotrophins - an Australian perspective.

  Norman RJ, de Lacey S, Wang JX. Norman RJ, et al. Reprod Biomed Online. 2005 Nov;11(5):542-3. doi: 10.1016/s1472-6483(10)61157-1. Reprod Biomed Online. 2005. PMID: 16409697
• Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies.

  Kelly E. Kelly E. Fertil Steril. 2003 Nov;80(5):1105-7. doi: 10.1016/s0015-0282(03)02186-1. Fertil Steril. 2003. PMID: 14607556 Review. No abstract available.
• The role of gonadotropins in ovulation induction.

  Olive DL. Olive DL. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 2):759-65. doi: 10.1016/0002-9378(95)90150-7. Am J Obstet Gynecol. 1995. PMID: 7872378 Review.